Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia

Indik, Julia H.; Marcus, Frank I.

doi:10.1007/978-1-4471-4978-1_4

Cited by 6 publications

(1 citation statement)

References 93 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…ARVD/C is an uncommon but important cause of SCD because most of these individuals are young. It is estimated that it accounts for one fifth of all episodes of SCD that occur in patients younger than the age of 35 years (13). During the past decade, 4 studies, predominantly in patients with sustained VT/VF, have demonstrated the efficacy of ICD therapy and its impact on SCD prevention.…”

Section: Discussionmentioning

confidence: 99%

Incidence and Predictors of Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Undergoing Implantable Cardioverter-Defibrillator Implantation for Primary Prevention

Bhonsale

James

Tichnell

et al. 2011

Journal of the American College of Cardiology

Self Cite

234

159

View full text Add to dashboard Cite

Nearly one-half of the ARVD/C patients with primary prevention ICD implantation experience appropriate ICD interventions. Inducibility at electrophysiologic study and nonsustained ventricular tachycardia are independent strong predictors of appropriate ICD therapy. An increase in ventricular ectopy burden was associated with progressively lower event-free (appropriate ICD interventions) survival. Incremental risk of ventricular arrhythmias and ICD therapy was observed with the presence of multiple risk factors.

show abstract

Section: Discussionmentioning

confidence: 99%